Research News

OCRA-Funded Research Provides a New Understanding of Ovarian Cancer Biology

OCRA-funded researcher Anil K. Sood, M.D., lead and senior author, and Sanghoon Lee, Ph.D…

Read on

Oral Contraceptives Tied to Lower Long-Term Ovarian Cancer Risk

A recent study, published in Cancer Research and reported in The New York Times, suggests that risk-reduction associated with oral contraceptive use can last a lifetime…

Read on

OCRA Research Investigates Role of Extracellular Vesicles in Cancer Research

OCRA-funded researchers Dr. Sunila Pradeep and Dr…

Read on

Applying Computational Biology to Ovarian Cancer | Meet a Scientist

Could the next ovarian cancer breakthrough be traced back to a Commodore 64 home computer? After all, in some small measure, OCRA grantee Dr. Sohrab Shah is where he is today thanks to that now-antiquated instrument…

Read on

OCRA-Funded Scientists Further Study Gene Mutation Connected to Ovarian Cancer

An international collaborative of scientists, including Dr. Ronald Chandler at Michigan State University, studied ARID1A mutations, which are specific gene mutations observed in deep ovarian and deep infiltrating endometriosis…

Read on

Focusing on the Next Line of Defense Against Ovarian Cancer | Meet a Scientist

There is an 80% recurrence rate when it comes to ovarian cancer, so the question of ‘what next?’ takes on a huge importance. This is the question that Sarah Gitto, PhD, and her team in the Daniel J…

Read on

OCRA-Funded Research Shines Light on Genetic Factors that Contribute to Diagnosis

In order to understand the complexities of how gene mutations affect an ovarian cancer diagnosis, OCRA-funded researcher Alexander Nikitin, MD, PhD and colleagues looked to see which ones drive, or possibly delay, the onset of the disease…

Read on

Heated Intraperitoneal Chemotherapy Found to Improve Outcomes in Patients with Stage III Epithelial Ovarian Cancer

A new study found that patients who received heated intraperitoneal chemotherapy (HIPEC) after surgery lived almost 16 months longer than patients who were treated by surgery alone…

Read on

OCRA Partners with Microsoft’s AI for Health Initiative

Ovarian Cancer Research Alliance (OCRA) is thrilled to announce a groundbreaking partnership with Microsoft’s AI for Health initiative…

Read on

New York City Researches Preliminary Outcomes of COVID-19 for Gynecologic Cancer Patients

(August 6, 2020) Using medical records for 121 patients with gynecologic cancer and COVID-19, researchers were able to conduct an early look at the implications of a COVID-19 diagnosis on a patient with a gynecological cancer diagnosis…

Read on

OCRA-Funded Study Finds Menopausal Hormone Therapy Associated with Improved Survival from Ovarian Cancer

(July 27, 2020) Research from the Ovarian Cancer Association Consortium (OCAC) found that “using menopausal hormone therapy prior to diagnosis extends ovarian cancer survival…

Read on

The Overview: July 2020

There’s so much happening at OCRA – from groundbreaking research to advocacy work, patient support to fundraising efforts. Starting this summer, we will share periodic highlights so that you can stay up to date on the latest…

Read on